Mira Pharmaceuticals MIRA
NASDAQ MIRA
$0.63 -0.05 (-7.35%)
At close: Oct 22, 2026 · 4:00 PM EDT

Mira Pharmaceuticals (MIRA) Cash from Financing Activities (2022 - 2025)

Updated

Mira Pharmaceuticals' Cash from Financing Activities was $4.84 million in the quarter ended Dec 31, 2025, up 881.0% from $493,401 a year earlier and up 60.9% from the prior quarter.

Analysis

Mira Pharmaceuticals (MIRA) Cash from Financing Activities (2022 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Cash from Financing Activities at Mira Pharmaceuticals came in at $8.18 million, up 115.7% from the prior year.

  • Cash from Financing Activities shows a three-year compound annual growth rate of 37.5% (years ended Dec 2022 to Dec 2025).
  • In earlier years, Cash from Financing Activities was $3.79 million in the year ended Dec 31, 2024 (-56.8%), $8.78 million in the year ended Dec 31, 2023 (+179.2%) and $3.15 million in the year ended Dec 31, 2022.
  • The figure for the quarter ended Dec 31, 2025 marks the highest quarterly Cash from Financing Activities since the quarter ended Sep 30, 2023.
  • Compared with a year earlier, Cash from Financing Activities was higher in two of the last five quarters, with growth averaging 168.9%.
  • Per Business Quant data, MIRA's Cash from Financing Activities in the three quarters before the quarter ended Dec 31, 2025 was $3.01 million (quarter ended Sep 30, 2025), $323,841 (quarter ended Jun 30, 2025) and $3,381 (quarter ended Mar 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 8.43 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn -8.53 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn -5.05 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn 1.76 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -2.02 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn -3.89 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn 2.34 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -3.66 Bn
10 Mira Pharmaceuticals 14.71 Mn -5.79 Mn - 4.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.84 Mn
Sep 30, 2025 3.01 Mn
Jun 30, 2025 323,841.00
Mar 31, 2025 3,381.00
Dec 31, 2024 493,401.00
Sep 30, 2024 3.16 Mn
Jun 30, 2024 159,015.00
Mar 31, 2024 -24,335.00
Dec 31, 2023 -230,749.00
Sep 30, 2023 7.60 Mn
Jun 30, 2023 684,287.00
Mar 31, 2023 725,677.00
Dec 31, 2022 1.14 Mn
Sep 30, 2022 676,422.00
API Access

Mira Pharmaceuticals Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=MIRA&period=max&api_key=YOUR_API_KEY